Companies
- Companies
- Browse
Companies
A DNA engineering company and inventors of Red/ET Recombination, a breakthrough DNA engineering platform. We engage in further innovative R&D and provide licenses and customized service. More
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
Consultancy to the Pharmaceutical Industry More
Training courses for pharmaceutical industry personnel More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 12 pages - $99
Mar 2010 - 19 pages - $1,495
May 2011 - 25 pages - $125
Aug 2008 - 117 pages - $2,350
Aug 2011 - 10 pages - $99
Mar 2011 - 23 pages - $250
Jun 2009 - 89 pages - $695
Aug 2011 - 320 pages - $2,350
Aug 2011 - 13 pages - $99
Sep 2011 - 11 pages - $99
Your selection
Browse By
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Geographic location
- Albania
- Andorra
- Austria
- Belgium
- Belorussia
- Bosnia-Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Greenland
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russia
- San Marino
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Yugoslavia
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us